サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1577497

老人用医薬品の世界市場

Geriatric Medicines

出版日
ページ情報
英文 304 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
老人用医薬品の世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 304 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

老人用医薬品の世界市場は2030年までに2,225億米ドルに到達

2023年に1,532億米ドルと推定される老人用医薬品の世界市場は、分析期間2023-2030年にCAGR 5.5%で成長し、2030年には2,225億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである降圧治療薬は、CAGR 6.8%を記録し、分析期間終了時には499億米ドルに達すると予測されます。鎮痛治療薬セグメントの成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は417億米ドルと推定、中国はCAGR 9.1％で成長予測

米国の老人用医薬品市場は2023年に417億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに472億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1%と5.6%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の老人用医薬品市場- 主要動向と促進要因のまとめ

老人用医薬品とは何か、なぜ高齢化社会に不可欠なのか？

老人用医薬品は、高齢患者が直面する特有の健康課題に対処するためにデザインされた特殊な医薬品です。高齢になると、高血圧、糖尿病、関節炎、認知障害などの慢性疾患など、複数の健康問題に直面することが多く、治療には集学的アプローチが必要となります。老人用医薬品は特にこのような層に対応し、高齢者に多く見られる症状に焦点を当て、生理学的・代謝学的ニーズにより適した治療法を提供しています。これらの医薬品は、疾病管理に対処するだけでなく、治療が副作用や他の医薬品との相互作用を最小限に抑えることを保証することにより、高齢者の全体的な生活の質を向上させる。先進国を中心に世界人口の高齢化が急速に進む中、新興諸国における医薬品の需要は増加の一途をたどっており、ヘルスケア産業にとって極めて重要な分野となっています。

医薬品の進歩は老年医学開発をどのように形成しているか？

医薬品の研究開発の進歩は、より効果的で安全な老人用医薬品の開発に大きな影響を与えています。イノベーションの主要な分野の一つは、高齢者特有の健康状態や加齢に伴うポリファーマシーの問題を考慮し、高齢者特有のニーズに合わせた個別化医薬品の開発です。高齢者が直面するコンプライアンスの課題に対処するため、徐放性製剤、併用療法、パッチや溶解錠などの服用しやすい薬剤が開発されています。さらにバイオテクノロジーは、アルツハイマー病、骨粗鬆症、心血管疾患など、高齢者に多く見られる疾患に対する標的療法を開発する上で重要な役割を果たしています。こうした進歩は治療成績を向上させるだけでなく、薬物相互作用や副作用のリスクを低減し、高齢者がより効果的に病状を管理できるようにします。

なぜ人口動態とヘルスケアシステムの変化が老人用医薬品の需要を牽引しているのか？

世界人口の高齢化は、老人用医薬品の需要を大きく牽引しています。平均寿命が延びるにつれて、特に北米、欧州、東アジアなどの地域では、高齢者の割合が急速に増加しています。この人口動態の変化により、ヘルスケアシステムは高齢者に適応し、適切な医療を提供することが急務となっています。政府やヘルスケアプロバイダーは、予防医療や加齢に伴う慢性疾患の管理に重点を置き、高齢者医療への投資を増やしています。さらに、新興市場ではヘルスケアのインフラが整備されるにつれて、高齢者医療へのアクセスが拡大し、専門的な医薬品への需要がさらに高まっています。加齢に関連した健康状態に対する一般市民の意識も高まっており、認知症、関節炎、心血管疾患などの早期診断や治療オプションに対する需要の高まりにつながっています。このような高齢者医療への関心の高まりは、ヘルスケアの状況を一変させ、老年医学をヘルスケアプロバイダーや製薬企業にとっての優先事項にしています。

老人用医薬品の世界市場成長の原動力は？

世界の老人用医薬品市場の成長は、医薬品開発の進歩、世界人口の高齢化、ヘルスケア投資の増加など、いくつかの要因によって牽引されています。主な成長要因の一つは、高齢者人口の拡大であり、これにより長期的な治療を必要とする慢性疾患の有病率が高まっています。製薬会社は、高齢患者特有のニーズに対応するため、よりターゲットを絞った治療法や革新的なドラッグデリバリーシステムを開発することで対応しています。さらに、バイオテクノロジーと個別化医療の進歩により、より効果的で副作用の少ない医薬品を生み出す新たな道が開かれつつあります。特に発展途上諸国では、ヘルスケア・インフラの整備に力を入れるようになり、より多くの人々が医療にアクセスしやすくなっています。さらに、政府やヘルスケア機関は、予防医療や高齢者の慢性疾患管理をより重視しており、特殊な医薬品に対する需要をさらに押し上げています。これらの要因が、高齢者の健康問題に対する人々の意識の高まりと相まって、世界の老人用医薬品市場の持続的成長に寄与しています。

調査対象企業の例（全52件）

  • AbbVie, Inc.
  • Adare Pharma Solutions
  • Akums Drugs & Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo Pharmaceuticals, Inc.
  • Ferring International Center SA
  • Fortis Healthcare Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24487

Global Geriatric Medicines Market to Reach US$222.5 Billion by 2030

The global market for Geriatric Medicines estimated at US$153.2 Billion in the year 2023, is expected to reach US$222.5 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Antihypertensive Therapeutics, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$49.9 Billion by the end of the analysis period. Growth in the Analgesics Therapeutics segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.7 Billion While China is Forecast to Grow at 9.1% CAGR

The Geriatric Medicines market in the U.S. is estimated at US$41.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$47.2 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Geriatric Medicines Market - Key Trends & Drivers Summarized

What Are Geriatric Medicines, and Why Are They Vital for an Aging Population?

Geriatric medicines are specialized drugs designed to address the unique health challenges faced by elderly patients. As people age, they often encounter multiple health issues, including chronic conditions like hypertension, diabetes, arthritis, and cognitive disorders, requiring a multidisciplinary approach to treatment. Geriatric medicines cater specifically to this demographic, focusing on conditions that are prevalent in older adults and providing therapies that are more appropriate for their physiological and metabolic needs. These medicines not only address disease management but also improve the overall quality of life for aging individuals by ensuring that treatment minimizes side effects and interactions with other medications. With the global population aging rapidly, especially in developed countries, the demand for geriatric medicines continues to grow, making it a crucial sector within the healthcare industry.

How Are Advances in Pharmaceuticals Shaping Geriatric Medicine Development?

Advances in pharmaceutical research and development are having a profound impact on the creation of more effective and safer geriatric medicines. One major area of innovation is the development of personalized medications that are tailored to the specific needs of elderly patients, taking into account their unique health conditions and the polypharmacy issues often associated with aging. Slow-release drug formulations, combination therapies, and easier-to-administer medications, such as patches and dissolvable tablets, are being developed to address compliance challenges that older adults face. Furthermore, biotechnology is playing a key role in creating targeted therapies for conditions such as Alzheimer’s, osteoporosis, and cardiovascular diseases, which are more prevalent in the geriatric population. These advancements not only improve treatment outcomes but also reduce the risk of drug interactions and side effects, ensuring that older adults can manage their conditions more effectively.

Why Are Changing Demographics and Healthcare Systems Driving Demand for Geriatric Medicines?

The aging global population is a significant driver of the demand for geriatric medicines. As life expectancy increases, the proportion of elderly individuals is growing rapidly, particularly in regions like North America, Europe, and East Asia. This demographic shift is creating an urgent need for healthcare systems to adapt and provide adequate medical care for older adults. Governments and healthcare providers are investing more in geriatric healthcare, with a focus on preventive care and the management of age-related chronic diseases. Additionally, as healthcare infrastructure improves in emerging markets, access to geriatric care is expanding, further fueling demand for specialized medicines. Public awareness of age-related health conditions is also increasing, leading to greater demand for early diagnosis and treatment options for conditions such as dementia, arthritis, and cardiovascular diseases. This growing focus on elderly care is transforming the healthcare landscape and making geriatric medicine a priority for healthcare providers and pharmaceutical companies alike.

What Is Driving the Growth of the Global Geriatric Medicines Market?

The growth in the global geriatric medicines market is driven by several factors, including advancements in drug development, an aging global population, and increased healthcare investment. One of the key growth drivers is the expanding elderly population, which is leading to a higher prevalence of chronic diseases that require long-term medical treatment. Pharmaceutical companies are responding by developing more targeted therapies and innovative drug delivery systems that cater to the specific needs of geriatric patients. Additionally, advancements in biotechnology and personalized medicine are opening new avenues for creating drugs that are more effective and have fewer side effects. The increasing focus on healthcare infrastructure improvements, especially in developing countries, is making geriatric medicines more accessible to a broader population. Furthermore, governments and healthcare organizations are placing a greater emphasis on preventive care and chronic disease management for the elderly, further driving the demand for specialized medicines. These factors, combined with growing public awareness of geriatric health issues, are contributing to the sustained growth of the global geriatric medicines market.

Select Competitors (Total 52 Featured) -

  • AbbVie, Inc.
  • Adare Pharma Solutions
  • Akums Drugs & Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo Pharmaceuticals, Inc.
  • Ferring International Center SA
  • Fortis Healthcare Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Geriatric Medicines - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Aging Population Throws Spotlight on the Increasing Demand for Geriatric Medicines
    • Increasing Prevalence of Age-Related Chronic Conditions Spurs Significant Growth in the Market for Geriatric Medicines
    • Technological Advancements in Drug Delivery Systems Strengthen the Business Case for Specialized Geriatric Formulations
    • Expansion of Elderly Healthcare Programs Expands Addressable Market for Geriatric Medicines Across Healthcare Systems
    • Growing Awareness of Preventive Healthcare and Early Intervention Propels Demand for Geriatric Medicines Focused on Disease Prevention
    • Increasing Focus on Personalized Medicine Drives Adoption of Tailored Geriatric Drug Regimens Based on Individual Health Profiles
    • Rising Incidence of Polypharmacy in the Elderly Generates Demand for Safer and More Compatible Geriatric Medicines
    • Shift Toward Home Healthcare and Telemedicine Expands Opportunities for Remote Monitoring of Geriatric Drug Therapies
    • Growing Popularity of Over-the-Counter (OTC) Geriatric Supplements Strengthens Market for Preventive Geriatric Healthcare
    • Increased Research and Development in Age-Related Diseases Drives Growth in Geriatric Medicines Targeting Dementia, Arthritis, and Cardiovascular Issues
    • Rising Focus on Palliative Care and Pain Management Expands the Market for Geriatric Medicines That Improve Quality of Life
    • Increased Use of Biotechnology and Gene Therapy Generates New Opportunities for Innovative Geriatric Medicines
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Geriatric Medicines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Geriatric Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antihypertensive Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antihypertensive Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antihypertensive Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analgesics Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analgesics Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Analgesics Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Antidiabetic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Antidiabetic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Antidiabetic Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Anticoagulant Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Anticoagulant Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Anticoagulant Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Statins Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Statins Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Statins Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Proton Pump Inhibitors Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Proton Pump Inhibitors Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Proton Pump Inhibitors Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Antipsychotic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Antipsychotic Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Antipsychotic Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Therapeutic Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Therapeutic Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • JAPAN
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • CHINA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • EUROPE
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Geriatric Medicines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • FRANCE
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • GERMANY
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Geriatric Medicines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • INDIA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 128: India Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 131: India Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Geriatric Medicines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Geriatric Medicines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Geriatric Medicines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030
  • AFRICA
    • Geriatric Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Geriatric Medicines by Therapeutic Type - Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Geriatric Medicines by Therapeutic Type - Percentage Breakdown of Value Sales for Antihypertensive Therapeutics, Analgesics Therapeutics, Antidiabetic Therapeutics, Anticoagulant Therapeutics, Statins Therapeutics, Proton Pump Inhibitors Therapeutics, Antipsychotic Therapeutics and Other Therapeutic Types for the Years 2014, 2024 & 2030
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Geriatric Medicines by Distribution Channel - Hospital Pharmacies, Online Pharmacies and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Geriatric Medicines by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies for the Years 2014, 2024 & 2030

IV. COMPETITION